Citation

80 FR 76504

Canonical document for this Federal Register citation.

Best Practices for Communication Between Investigational New Drug Sponsors and Food and Drug Administration During Drug Development; Draft Guidance for Industry and Review Staff; Availability Wednesday, December 9, 2015 80 FR 76504